T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FARO
1701
DELISTED
Faro Technologies
FARO
| $1.41M | ﹤0.01% |
26,825
+48
| +0.2% | +$2.43K |
|
1702
Silicon Laboratories
SLAB
$7.3B
| $1.41M | ﹤0.01% |
13,607
+1,606
| +13% | +$155K |
|
|
MDP
1703
DELISTED
Meredith Corporation
MDP
| $1.41M | ﹤0.01% |
25,563
+100
| +0.4% | +$5.6K |
|
|
VRNT
1704
DELISTED
Verint Systems
VRNT
| $1.4M | ﹤0.01% |
51,095
+5,253
| +11% | +$158K |
|
1705
MBIA
MBI
$254M
| $1.39M | ﹤0.01% |
149,657
+60,461
| +68% | +$564K |
|
1706
IAMGOLD
IAG
$10.3B
| $1.39M | ﹤0.01% |
+409,939
| New | +$1.2M |
|
|
FNSR
1707
DELISTED
Finisar Corp
FNSR
| $1.38M | ﹤0.01% |
60,420
+518
| +0.9% | +$11.9K |
|
1708
MillerKnoll
MLKN
$1.64B
| $1.38M | ﹤0.01% |
30,755
+142
| +0.5% | +$5.37K |
|
1709
Sensient Technologies
SXT
$5.53B
| $1.38M | ﹤0.01% |
18,713
+200
| +1% | +$14.1K |
|
|
SF
1710
Stifel
SF
$12.8B
| $1.37M | ﹤0.01% |
52,297
+356
| +0.7% | +$9.06K |
|
1711
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $1.36M | ﹤0.01% |
4,644
-200
| -4% | -$57.6K |
|
1712
Ashland
ASH
$3.42B
| $1.36M | ﹤0.01% |
16,965
+17
| +0.1% | +$1.31K |
|
1713
Avis
CAR
$4.93B
| $1.36M | ﹤0.01% |
38,590
-7,571
| -16% | -$254K |
|
1714
FNB Corp
FNB
$6.86B
| $1.36M | ﹤0.01% |
115,213
+762
| +0.7% | +$8.79K |
|
1715
Teradata
TDC
$2.49B
| $1.35M | ﹤0.01% |
37,772
+6
| +0% | +$234 |
|
1716
National Healthcare
NHC
$3.47B
| $1.35M | ﹤0.01% |
16,631
-31,073
| -65% | -$2.4M |
|
1717
Ryder
R
$10.1B
| $1.35M | ﹤0.01% |
23,110
+12
| +0.1% | +$714 |
|
1718
RE/MAX Holdings
RMAX
$263M
| $1.34M | ﹤0.01% |
43,691
+2,700
| +7% | +$97K |
|
1719
Viasat
VSAT
$12B
| $1.34M | ﹤0.01% |
16,605
-154
| -0.9% | -$13.5K |
|
1720
Genworth Financial
GNW
$3.79B
| $1.34M | ﹤0.01% |
360,695
+1,323
| +0.4% | +$4.69K |
|
|
MODV
1721
DELISTED
ModivCare
MODV
| $1.34M | ﹤0.01% |
23,296
-1,265
| -5% | -$82K |
|
1722
Archrock
AROC
$5.84B
| $1.33M | ﹤0.01% |
125,917
+287
| +0.2% | +$2.82K |
|
1723
Cinemark Holdings
CNK
$4.32B
| $1.33M | ﹤0.01% |
36,990
+31
| +0.1% | +$1.22K |
|
|
ORIT
1724
DELISTED
Oritani Financial Corp. New
ORIT
| $1.33M | ﹤0.01% |
75,277
+134
| +0.2% | +$2.24K |
|
1725
First Bancorp
FBP
$4.46B
| $1.32M | ﹤0.01% |
119,988
+9,190
| +8% | +$98.8K |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.